ABG Innovation Capital Partners III GP Ltd Long-Term Concentrated

Name: ABG Innovation Capital Partners III GP Ltd Q4 2022 13F Filing | 13F Explorer
Creator: ABG Innovation Capital Partners III GP Ltd
Published: 2023-02-14

Location: Central, Hong Kong, Hong Kong

CIK: 0001845297 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value: $1.31M (100.0% shares, 0.0% debt)

Holdings (4)

CSTL CASTLE BIOSCIENCES INC 60.4%

Value $792K Shares 33,626 Est. Cost $23.24 Unrealized -0.2%

WHWK AADI BIOSCIENCES INC 26.1%

Value $342K Shares 26,666 Est. Cost $30.48 Unrealized -57.2%

— SYNLOGIC INC 11.9%

Value $156K Shares 205,906 Est. Cost $2.16 Unrealized —

— IDERA PHARMACEUTICALS INC 1.5%

Value $19,688 Shares 56,250 Est. Cost $3.66 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CSTL	CASTLE BIOSCIENCES INC	33,626	$792K	60.4%	$23.24	-0.2%	COM	14843C105
WHWK	AADI BIOSCIENCES INC	26,666	$342K	26.1%	$30.48	-57.2%	COM	00032Q104
—	SYNLOGIC INC	205,906	$156K	11.9%	$2.16	—	COM	87166L100
—	IDERA PHARMACEUTICALS INC	56,250	$19,688	1.5%	$3.66	—	COM PAR	45168K405